RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 45.84

Change

+0.44 (+0.97)%

Market Cap

N/A

Volume

5.80K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-08 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-0.97 (-3.11%)

USD 9.92B
FNGU MicroSectors FANG+ Index 3X Le..

-4.39 (-0.72%)

USD 7.96B
QLD ProShares Ultra QQQ

+0.02 (+0.02%)

USD 7.84B
SSO ProShares Ultra S&P500

+0.17 (+0.18%)

USD 5.60B
UPRO ProShares UltraPro S&P500

+0.24 (+0.27%)

USD 4.27B
TECL Direxion Daily Technology Bull..

-0.06 (-0.07%)

USD 3.43B
YINN Direxion Daily FTSE China Bull..

-0.37 (-1.44%)

USD 1.61B
USD ProShares Ultra Semiconductors

-0.43 (-0.62%)

USD 1.16B
UDOW ProShares UltraPro Dow30

+0.47 (+0.50%)

USD 0.91B
LABU Direxion Daily S&P Biotech Bul..

-1.76 (-1.79%)

USD 0.82B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

-0.67 (0%)

USD 0.09B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

-0.43 (0%)

USD 8.38B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

-0.81 (0%)

USD 0.21B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

-0.66 (0%)

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.21% 82% B 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.21% 82% B 91% A-
Trailing 12 Months  
Capital Gain -5.93% 18% F 23% F
Dividend Return 1.59% 71% C- 26% F
Total Return -4.34% 18% F 20% F
Trailing 5 Years  
Capital Gain 41.23% 67% D+ 70% C-
Dividend Return 4.01% 66% D+ 10% F
Total Return 45.24% 67% D+ 65% D
Average Annual (5 Year Horizon)  
Capital Gain 12.09% 30% F 69% C-
Dividend Return 12.38% 28% F 65% D
Total Return 0.29% 22% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 31.37% 97% N/A 34% F
Risk Adjusted Return 39.47% 67% D+ 54% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.